Table 1. Key study characteristics.
Study characteristic | Number reported | Category/Statistic | Value | Percentage |
---|---|---|---|---|
Study aim | 192 | Diagnostic agreement | 44 | 22.9% |
Prevalence | 37 | 19.3% | ||
Clinical severity | 29 | 15.1% | ||
Intervention | 28 | 14.6% | ||
Risk factors | 27 | 14.1% | ||
Immunological profiling | 21 | 10.9% | ||
Liver function | 17 | 8.9% | ||
Co-infections | 17 | 8.9% | ||
Genetic/genomic | 9 | 4.7% | ||
Pathogenesis | 8 | 4.2% | ||
Age of participants | 181 | Pre-school age children | 27 | 14.9% |
School-age children | 94 | 51.9% | ||
Adults | 165 | 91.1% | ||
Range (years) | 0–97 | - | ||
Sex of participants | 189 | No restriction | 185 | 97.9% |
Male-only | 3 | 1.6% | ||
Female-only | 1 | 0.5% | ||
Sample size | 192 | Total | 122798 | - |
Mean (std. dev.) | 640 (2168) | - | ||
Range | 8–22488 | - | ||
Interquartile range | 79.5–487.5 | - | ||
Study duration | 107 | Mean (std. dev.) (months) | 24.9 (43.4) | - |
Range (months) | 1–300 | - | ||
Study sittings | 192 | One | 159 | 82.8% |
Two | 16 | 8.3% | ||
Three | 10 | 5.2% | ||
More than three | 7 | 3.6% | ||
Study setting | 180 | Community | 110 | 61.1% |
Hospital | 66 | 36.7% | ||
School | 10 | 5.6% | ||
Study locality | 181 | Rural | 123 | 68.0% |
Peri-urban | 9 | 5.0% | ||
Urban | 55 | 30.4% | ||
Study design | 192 | Cross-sectional | 165 | 85.9% |
Before-and-after | 19 | 9.9% | ||
Cohort | 11 | 5.7% | ||
Case-control | 3 | 1.6% | ||
Randomised controlled trial | 2 | 1.0% | ||
Sampling strategy | 151 | Purposive | 78 | 51.7% |
Random | 30 | 19.9% | ||
Convenience | 19 | 12.6% | ||
Census | 15 | 9.9% | ||
Systematic | 8 | 5.3% | ||
Stratified | 3 | 2.0% | ||
Schistosoma species | 192 | S. mansoni | 149 | 77.6% |
S. japonicum | 41 | 21.3% | ||
S. mekongi | 2 | 1.0% |